𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients with Advanced Solid Tumors

✍ Scribed by Gerber, D. E.; Stopeck, A. T.; Wong, L.; Rosen, L. S.; Thorpe, P. E.; Shan, J. S.; Ibrahim, N. K.


Book ID
111884000
Publisher
American Association for Cancer Research
Year
2011
Tongue
English
Weight
346 KB
Volume
17
Category
Article
ISSN
1078-0432

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES